ASTEC Intraday Analysis...

ASTEC Share Price

Open 606.95 Change Price %
High 614.95 1 Day 1.15 0.19
Low 601.25 1 Week 16.05 2.73
Close 604.90 1 Month -11.90 -1.93
Volume 28454 1 Year 409.10 208.94
52 Week High 694.00
52 Week Low 170.00
ASTEC Important Levels
Resistance 2 617.60
Resistance 1 612.37
Pivot 607.03
Support 1 597.43
Support 2 592.20
NSE INDIA Most Active Stocks
SUZLON 17.50 0.86%
ICICIBANK 257.55 -2.24%
ADANIPOWER 34.75 1.16%
VISESHINFO 0.20 -20.00%
GMRINFRA 12.55 -1.18%
HINDALCO 181.70 5.85%
JPASSOCIAT 10.00 1.52%
AXISBANK 445.00 -1.28%
IDEA 73.35 2.59%
IBREALEST 80.60 -0.86%
More..
NSE INDIA Top Gainers Stocks
BHARATRAS 2279.55 20.00%
PRAKASHSTL 1.80 20.00%
ORIENTHOT 26.75 19.96%
BHAGYNAGAR 25.25 19.95%
OISL 6.05 19.80%
HOVS 161.40 16.03%
KTIL 234.55 12.93%
NAKODA 0.45 12.50%
DLINKINDIA 125.45 11.76%
BLUECHIP 0.50 11.11%
More..
NSE INDIA Top Losers Stocks
KSERASERA 0.15 -25.00%
VISESHINFO 0.20 -20.00%
SRGINFOTEC 0.35 -12.50%
HOTELRUGBY 4.10 -11.83%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
ESL 5.40 -9.24%
SAMTEL 0.50 -9.09%
TECHIN 3.90 -8.24%
More..

Astec LifeSciences Limited (NSE: ASTEC)

ASTEC Technical Analysis 4
As on 23rd Jan 2017 ASTEC Share Price closed @ 604.90 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 382.15 & Buy for SHORT-TERM with Stoploss of 592.37 we also expect STOCK to react on Following IMPORTANT LEVELS.
ASTEC Target for January
1st Target up-side 683.13
2nd Target up-side 728.4
3rd Target up-side 773.67
1st Target down-side 553.97
2nd Target down-side 508.7
3rd Target down-side 463.43
ASTEC Synopsis Technicals View
50 Day EMA N/A (Short Term)
N/A
100 Day EMA N/A (Mid Term) N/A
200 Day EMA N/A (Long Term) N/A
MACD (12 26 9) N/A N/A
RSI (14) N/A N/A
MFI (14) N/A N/A
CCI (20) N/A N/A
WILLIAM %R (14) N/A N/A
ADX (14) N/A N/A
PSAR N/A N/A
10 Day Avg Volume N/A
ASTEC Other Details
Segment EQ
Market Capital 0.00
Sector Basic Materials
Industry Chemicals - Major Diversified
Offical website http://www.astecls.com
ASTEC Address
ASTEC
Elite Square
7th Floor
Mumbai, 400001
India
Phone: 91 22 2261 8212
Fax: 91 22 2261 8289
ASTEC Latest News
Astec Lifesciences Ltd reply to clarification sought by the exchange   Hindu Business Line   - 11th Mar 15
Clarification sought from Astec Lifesciences Ltd   Hindu Business Line   - 11th Mar 15
Astec Lifesciences Ltd reappoints Chairman & MD   Equity Bulls   - 06th Mar 15
Astec LifeSciences Limited   Moneycontrol.com   - 05th Mar 15
Astec Lifesciences Ltd to consider reappointment of directors   Equity Bulls   - 04th Mar 15
Astec Lifesciences Ltd announces closure of trading window for Q3 results   Equity Bulls   - 22nd Jan 15
Astec Lifesciences' board meeting on January 31, 2015   Moneycontrol.com   - 21st Jan 15
Astec Lifesciences temporarily stops operation at Dombivali plant   Business Standard   - 26th Mar 14
Astec Lifesciences Ltd posts Q2 profit of Rs. 3.45 crore   Equity Bulls   - 24th Oct 13
Astec Lifesciences commissions new facility in MIDC at Mahad   Equity Bulls   - 18th Jun 12
Interactive Technical Analysis Chart Astec LifeSciences Limited ( ASTEC NSE INDIA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Astec LifeSciences Limited
ASTEC Business Profile
Astec LifeSciences Ltd is a producer of agrochemicals and pharmaceutical intermediates. The company manufactures a wide range of Agrochemical active ingredients and pharmaceutical intermediates. They are having manufacturing facilities located at two locations in Maharashtra, India comprising of three units viz. one unit at Dombivli, Maharashtra and two units at Mahad, Maharashtra (Unit 1 and Unit 2). They are exporting their products to East Asia, Europe, Middle East, and USA. The business of the company comprises of the two major segments, namely Agrochemicals and Pharmaceuticals. Under the Agrochemical segment, the company manufactures active ingredients, intermediates and formulations. The current market capitalization stands at Rs 54.66 crore.The company has reported a consolidated sales of Rs 67.61 crore and a Net Profit of Rs 3.46 crore for the quarter ended September 2013. The company management includes Laxmikant Kabra - Non Exe.Non Ind.Director, P L Tiwari - Non Exe.Non Ind.Director, Ashok V Hiremath - Chairman & Managing Director, Janak Jaganath Rawal - Whole Time Director, Mandar K Patil - Ind. Non-Executive Director, Mohammed Zakir - Ind. Non-Executive Director, Sitendu Sharma - Ind. Non-Executive Director, Vinod Malshe - Ind. Non-Executive Director. The Registered office is at Elite Square, 7th Floor, 274, Perin Nariman Street, Fort Mumbai, Maharashtra - 400001.